Role of adjunct anticoagulant or thrombolytic therapy in cardiac arrest without ST-segment-elevation or percutaneous coronary intervention: A systematic review and meta-analysis.
The American journal of emergency medicine · 2022-10-19 · Meta-analysis
Abstract
This study sought to compare the impact of additional anticoagulation or thrombolytic therapy in patients with cardiac arrest without ST-segment-elevation on electrocardiography and not receiving percutaneous coronary intervention. Three studies (two randomized controlled studies and one observational study) were included, which demonstrated that use of anticoagulation or thrombolytic therapy was associated with higher risk of bleeding, without improvements in time to return of spontaneous circulation or in-hospital mortality.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Oral anticoagulants · Antithrombotics & thrombolytics · Mortality & survival · Thrombolytics
Related articles
- Intra-arrest systemic thrombolytic therapy during cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled trials. (Resusc Plus, 2026)
- Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis. (Clin Neurol Neurosurg, 2024)
- Thrombolytics in Cardiac Arrest from Pulmonary Embolism: A Systematic Review and Meta Analysis. (J Intensive Care Med, 2024)
- Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. (CMAJ, 2023)
- Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis. (Eur Stroke J, 2023)
- Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis. (Stroke, 2020)